Bio-pharma data is complex, fragmented, and unstructured. We transform raw clinical inputs into AI-ready assets, bridging the gap between static databases and predictive intelligence.
Designed for FDA-grade compliance and clinical rigor.
80% of clinical research time is lost to data cleaning. Unstructured PDFs, siloed EMRs, and messy spreadsheets create a "Trust Void"—where valuable insights are buried under noise, delaying trials and risking compliance.
Intelligent Analyst acts as the computational trust layer. We ingest, validate, and structure your data automatically. The result is a clean, immutable dataset ready for advanced analytics and machine learning.
Move from raw ingestion to analysis in minutes, not months. Accelerate your time-to-insight.
Context-aware algorithms that understand clinical terminology, not just keywords.
End-to-end audit trails designed for the rigorous demands of the pharma industry.
Our engine standardizes chaos into compliance-ready assets in three stages.
We bypass format limitations. Whether it is unstructured PDF reports or legacy spreadsheets, we absorb data at the source.
Our AI maps disparate data points to a unified ontology, resolving duplicates with higher precision than human review.
Data is finalized into an immutable, audit-ready format. Ready for FDA submission and strategic decisions.
We founded Intelligent Analyst because we saw a critical failure in the life sciences: the worldd's most important data was being managed by the worldd's most outdated tools.
Our leadership brings decades of experience establishing rigorous compliance standards at organizations like Global RADAR. We apply that same rigor of financial and regulatory compliance to the chaotic world of biotech data.
Co-Founder & Strategy
Project Lead & Engineering